Dentons advised The Protein Brewery, an innovative developer of protein-rich food ingredients, replacing animals in the food chain, with the raise of a €22 million Series A investment, bringing its total funding to date to €26 million.
The latest funding will enable the company to continue its research and development, cover operational costs as well as scaling up production of the Fermotein food ingredient. With Fermotein, the company is well positioned to enter a €30 billion-plus market for alternative proteins, a market with huge growth potential. TPB is headquartered in Breda, the Netherlands, working with a team of 20 professionals.
The Amsterdam team consisted of Casper Haket (Partner, M&A), Tjibbe Douma (Partner, IP), Bastiaan van Rath (Senior Associate, M&A), Rogier van der Weijden (Junior Associate, M&A) and Alexandra Michel (Junior Associate, IP).
Read the press release from The Protein Brewery here.
